Filing Details
- Accession Number:
- 0001127602-15-022491
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-07-07 14:03:35
- Reporting Period:
- 2015-07-06
- Filing Date:
- 2015-07-07
- Accepted Time:
- 2015-07-07 14:03:35
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1110803 | Illumina Inc | ILMN | Laboratory Analytical Instruments (3826) | 330804655 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1236397 | Daniel Bradbury | 5200 Illumina Way San Diego CA 92122 | Yes | No | No | No |
Transaction Summary
Sold: | 1,700 shares | Avg. Price: $219.70 | Total Value: $373,487.50 |
Number of Shares After Transactions: | 14,376 shares |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-07-06 | 1,700 | $75.66 | 16,076 | No | 4 | M | Direct | |
Common Stock | Disposition | 2015-07-06 | 500 | $218.67 | 15,576 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-07-06 | 900 | $219.89 | 14,676 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-07-06 | 300 | $220.84 | 14,376 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-qualified Stock Option (Right to Buy) | Disposition | 2015-07-06 | 1,700 | $0.00 | 1,700 | $75.66 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
2,300 | 2012-04-17 | 2021-05-10 | No | 4 | M | Direct |
Footnotes
- The sale was made pursuant to a 10b5-1 plan.
- Weighted average sale price representing 500 shares sold ranging from $218.37 to $219.27 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 900 shares sold ranging from $219.46 to $220.43 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 300 shares sold ranging from $220.71 to $221.04 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.